Helix-loop-helix proteins and lymphocyte development (original) (raw)

References

1. Lazorchak, A., Jones, M.E. & Zhuang, Y. New insights into E-protein function in lymphocyte development. Trends Immunol. 26, 334–338 (2005).
   CAS PubMed Google Scholar
2. Sun, X.H. Multitasking of helix-loop-helix proteins in lymphopoiesis. Adv. Immunol. 84, 43–77 (2004).
   CAS PubMed Google Scholar
3. Bain, G., Gruenwald, S. & Murre, C. E2A and E2–2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol. Cell. Biol. 13, 3522–3529 (1993).
   CAS PubMed PubMed Central Google Scholar
4. Sloan, S.R., Shen, C.P., McCarrick-Walmsley, R. & Kadesch, T. Phosphorylation of E47 as a potential determinant of B-cell-specific activity. Mol. Cell. Biol. 16, 6900–6908 (1996).
   CAS PubMed PubMed Central Google Scholar
5. Shen, C.P. & Kadesch, T. B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15, 4518–4524 (1995).
   CAS PubMed PubMed Central Google Scholar
6. Sawada, S. & Littman, D.R. A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell. Biol. 13, 5620–5628 (1993).
   CAS PubMed PubMed Central Google Scholar
7. Murre, C., McCaw, P.S. & Baltimore, D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56, 777–783 (1989).
   CAS PubMed Google Scholar
8. Aronheim, A., Shiran, R., Rosen, A. & Walker, M.D. The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc. Natl. Acad. Sci. USA 90, 8063–8067 (1993).
   CAS PubMed PubMed Central Google Scholar
9. Quong, M.W., Massari, M.E., Zwart, R. & Murre, C. A new transcriptional-activation motif restricted to class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol. Cell. Biol. 13, 792–800 (1993).
   CAS PubMed PubMed Central Google Scholar
10. Massari, M.E., Jennings, P.A. & Murre, C. The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells. Mol. Cell. Biol. 16, 121–129 (1996).
    CAS PubMed PubMed Central Google Scholar
11. Sun, X.H. & Baltimore, D. An inhibitory domain of the E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64, 459–470 (1991).
    CAS PubMed Google Scholar
12. Massari, M.E. & Murre, C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20, 429–440 (2000).
    CAS PubMed PubMed Central Google Scholar
13. Corneliussen, B., Thornell, A., Hallberg, B. & Grundstrom, T. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J. Virol. 65, 6084–6093 (1991).
    CAS PubMed PubMed Central Google Scholar
14. Rothenberg, E.V. (2002). T-lineage specification and commitment: a gene regulation perspective. Sem. Immunol. 14, 431–440 (2002).
    CAS Google Scholar
15. Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L. & Weintraub, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49–59 (1990).
    CAS PubMed Google Scholar
16. Norton, J.D. Id helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113, 3897–3905 (2000).
    CAS PubMed Google Scholar
17. Yan, W. et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17, 7317–7327 (1997).
    CAS PubMed PubMed Central Google Scholar
18. Rivera, R.R., Johns, C.P., Quan, J., Johnson, R.S. & Murre, C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 12, 17–26 (2000).
    CAS PubMed Google Scholar
19. Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702–706 (1999).
    Article CAS PubMed Google Scholar
20. Pan, L., Sato, S., Frederick, J.P., Sun, X.H. & Zhuang, Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 19, 5969–5980 (1999).
    CAS PubMed PubMed Central Google Scholar
21. Ikawa, T., Kawamoto, H., Wright, L.Y.T. & Murre, C. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 3, 349–360 (2004).
    Google Scholar
22. Massari, M.E. et al. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell 4, 63–73 (1999).
    CAS PubMed Google Scholar
23. Qiu, Y., Sharma, A. & Stein, R. p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol. Cell. Biol. 18, 2957–2964 (1998).
    CAS PubMed PubMed Central Google Scholar
24. Bradney, C. et al. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J. Biol. Chem. 278, 2370–2376 (2002).
    PubMed Google Scholar
25. Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T. & Roeder, R.G. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 305, 1286–1289 (2004).
    CAS PubMed Google Scholar
26. Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu. Rev. Immunol. 21, 759–806 (2003).
    CAS PubMed Google Scholar
27. Allman, D. et al. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4, 168–174 (2003).
    CAS PubMed Google Scholar
28. Schwartz, B.A. & Bhandoola, A. Circulating hematopoietic progenitors with T lineage potential. Nat. Immunol. 5, 953–960 (2004).
    Google Scholar
29. Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547–558 (1999).
    CAS PubMed Google Scholar
30. Pui, J.C. et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11, 299–308 (1999).
    CAS PubMed Google Scholar
31. Rothenberg, E.V. & Taghon, T. Molecular genetics of T cell development. Annu. Rev. Immunol. 23, 601–649 (2005).
    CAS PubMed Google Scholar
32. Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885–892 (1994).
    CAS PubMed Google Scholar
33. Zhuang, Y., Soriano, P. & Weintraub, H. The helix-loop-helix gene E2A is required for B cell formation. Cell 79, 875–884 (1994).
    CAS PubMed Google Scholar
34. Sun, X.H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79, 893–900 (1994).
    CAS PubMed Google Scholar
35. Heemskerk, M.H. et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix-loop-helix factor Id3. J. Exp. Med. 186, 1597–1602 (1997).
    CAS PubMed PubMed Central Google Scholar
36. Bain, G. et al. E2A deficiency leads to abnormalities in T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17, 4782–4791 (1997).
    CAS PubMed PubMed Central Google Scholar
37. Barndt, R.J., Dai, M. & Zhuang, Y. Functions of E2A/HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB. Mol. Cell. Biol. 20, 6677–6685 (2000).
    CAS PubMed PubMed Central Google Scholar
38. Spits, H., Couwenberg, F., Bakker, A.Q., Weijer, K. & Uittenbogaart, C.H. Id2 and Id3 inhibit development of CD34+ stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 192, 1775–1784 (2000).
    CAS PubMed PubMed Central Google Scholar
39. Zhuang, Y., Jackson, A., Pan, L., Shen, K. & Dai, M. Regulation of E2A gene expression in B lymphocyte development. Mol. Immunol. 40, 1165–1170 (2004).
    CAS PubMed Google Scholar
40. Shivdasani, R.A., Mayer, E.L. & Orkin, S.H. Absence of blood formation in mice lacking the T-cell leukemia protein tal-1/SCL. Nature 373, 432–443 (1995).
    CAS PubMed Google Scholar
41. Ying, Q., Nichols, J., Chambers, I. & Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281–292 (2003).
    CAS PubMed Google Scholar
42. Igarashi, H., Gregory, S., Yokota, T., Sakaguchi, N. & Kincade, P.W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17, 117–130 (2002).
    CAS PubMed Google Scholar
43. Singh, H., Medina, K.L. & Pongubala, J.M.R. Contingent gene regulatory networks and B cell fate specification. Proc. Natl. Acad. Sci. USA 102, 4945–4953 (2005).
    Google Scholar
44. Busslinger, M. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22, 55–79 (2004).
    CAS PubMed Google Scholar
45. Jaleco, A.C. et al. Genetic modification of human B cell development: B cell development is inhibited by the dominant-negative helix-loop-helix factor Id3. Blood 94, 2637–2646 (1999).
    CAS PubMed Google Scholar
46. Bain, G. et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6, 145–154 (1997).
    CAS PubMed Google Scholar
47. Zhuang, Y., Cheng, P. & Weintraub, H. B lymphocyte development is regulated by the combined dosage of three helix-loop-helix genes, E2A, E2–2 and HEB. Mol. Cell. Biol. 16, 2898–2905 (1996).
    CAS PubMed PubMed Central Google Scholar
48. Hagman, J., Belanger, C., Travis, A., Turck, C.W. & Grosschedl, R. Cloning and characterization of early B-cell factor, a regulator of lymphocyte specific gene expression. Genes Dev. 5, 760–773 (1993).
    Google Scholar
49. Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263–267 (1995).
    CAS PubMed Google Scholar
50. Urbanek, P., Wang, Z., Fetka, I., Wagner, E.F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901–912 (1994).
    CAS PubMed Google Scholar
51. Hesslein, D.G. et al. Pax5 is required for recombination of transcribed, acetylated, 5′ IgH V gene segments. Genes Dev. 1, 37–42 (2003).
    Google Scholar
52. Seet, C.S., Brumbaugh, R.L. & Kee, B.L. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J. Exp. Med. 199, 1689–1700 (2004).
    CAS PubMed PubMed Central Google Scholar
53. Kee, B.L. & Murre, C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J. Exp. Med. 188, 699–713 (1998).
    CAS PubMed PubMed Central Google Scholar
54. O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21–31 (1999).
    CAS PubMed Google Scholar
55. Nutt, S.L., Heavey, B., Rolink, A.G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401, 556–562 (1999).
    CAS PubMed Google Scholar
56. Maier, H. et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immunol. 5, 1069–1077 (2004).
    CAS PubMed Google Scholar
57. Quong, M.W. et al. Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. J. Exp. Med. 199, 1113–1120 (2004).
    Google Scholar
58. Greenbaum, S., Lazorchak, A.S. & Zhuang, Y. Differential functions for the transcription factor E2A in positive and negative regulation in pre-B lymphocytes. J. Biol. Chem. 279, 45028–45035 (2004).
    CAS PubMed Google Scholar
59. Schebesta, M., Pfeffer, P.L. & Busslinger, M. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 17, 473–485 (2002).
    CAS PubMed Google Scholar
60. Herblot, S., Aplan, P.D. & Hoang, T. Gradient of E2A activity in B cell development. Mol. Cell. Biol. 22, 886–900 (2002).
    CAS PubMed PubMed Central Google Scholar
61. Hsu, L. et al. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19, 105–117 (2003).
    CAS PubMed Google Scholar
62. Romanow, W.J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5, 343–353 (2000).
    CAS PubMed Google Scholar
63. Inlay, M.A., Tian, H., Lin, T. & Xu, Y. Important roles for E protein binding sites within the immunoglobulin κ chain intronic enhancer in activating VJk rearrangement. J. Exp. Med. 9, 1205–1211 (2004).
    Google Scholar
64. Goebel, P. et al. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and EBF in non lymphoid cells. J. Exp. Med. 194, 645–656 (2001).
    CAS PubMed PubMed Central Google Scholar
65. Bain, G. Romanow, W.J., Albers, K. Havran, W.L. & Murre, C. Positive and negative regulation of V(D)J recombination by the E2A proteins. J. Exp. Med. 189, 289–300 (1999).
    CAS PubMed PubMed Central Google Scholar
66. Bergman, Y. & Cedar, H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat. Rev. Immunol. 4, 753–761 (2004).
    CAS PubMed Google Scholar
67. Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J.V. J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1, 31–36 (2000).
    CAS PubMed Google Scholar
68. Tanigaki, K. et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3, 443–450 (2002).
    CAS PubMed Google Scholar
69. Quong, M.W., Harris, D.P., Swain, S.L. & Murre, C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18, 6307–6318 (1999).
    CAS PubMed PubMed Central Google Scholar
70. Sayegh, C.E., Quong, M.E., Agata, Y. & Murre, C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4, 586–593 (2003).
    CAS PubMed Google Scholar
71. Michael, N. et al. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19, 235–242 (2003).
    CAS PubMed Google Scholar
72. Goldfarb, A.N., Flores, J.P. & Lewandowska, K. Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching. Mol. Immunol. 33, 947–956 (1996).
    CAS PubMed Google Scholar
73. Roberts, V.J., Steenbergen, R. & Murre, C. Localization of E2A mRNA expression in developing and adult rat tissues. Proc. Natl. Acad. Sci. USA 90, 7583–7587 (1993).
    CAS PubMed PubMed Central Google Scholar
74. Gonda, H. et al. The balance between Pax5 and Id2 activities is the key to AID expression. J. Exp. Med. 198, 1427–1437 (2003).
    CAS PubMed PubMed Central Google Scholar
75. Ikawa, T., Fujimoto, S., Kawamoto, H., Katsura, Y. & Yokota, Y. Commitment to natural killer cells requires the helix-loop-helix protein, Id2. Proc. Natl. Acad. Sci. USA 98, 5164–5169 (2001).
    CAS PubMed PubMed Central Google Scholar
76. Hacker, C. et al. Transcription profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4, 380–386 (2003).
    CAS PubMed Google Scholar
77. Engel, I., Johns, C., Bain, G., Rivera, R.R. & Murre, C. Early thymocyte development is regulated by modulation of E2A protein activity. J. Exp. Med. 194, 733–745 (2001).
    CAS PubMed PubMed Central Google Scholar
78. Herblot, S. et al. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expression. Nat. Immunol. 1, 138–144 (2000).
    CAS PubMed Google Scholar
79. Schlissel, M., Voronova, A. & Baltimore, D. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev. 5, 1367–1376 (1991).
    CAS PubMed Google Scholar
80. Engel, I. & Murre, C. E2A proteins enforce a proliferation checkpoint in developing thymocytes. EMBO J. 23, 202–211 (2004).
    CAS PubMed Google Scholar
81. Bain, G., Quong, M.W., Soloff, R.S., Hedrick, S.M. & Murre, C. Thymocyte maturation is regulated by the activity of the helix-loop-helix protein, E47. J. Exp. Med. 190, 1605–1616 (1999).
    CAS PubMed PubMed Central Google Scholar
82. Bain, G. et al. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat. Immunol. 2, 165–171 (2001).
    CAS PubMed Google Scholar
83. Costello, P.S., Nicolas, R.H., Watanabe, Y., Rosewell, I. & Treisman, R. Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection. Nat. Immunol. 5, 289–298 (2004).
    CAS PubMed Google Scholar
84. Bettini, M., Xi, H., Milbrandt, J. & Kersh, G.J. Thymocyte development in early growth response gene 1-deficient mice. J. Immunol. 169, 1713–1720 (2002).
    CAS PubMed Google Scholar
85. Kee, B.L., Rivera, R.R. & Murre, C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat. Immunol. 2, 242–247 (2001).
    CAS PubMed Google Scholar
86. Hollnagel, A., Oehlmann, V., Heymeyer, J., Ruther, U. & Nordheim, A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838–19845 (1999).
    CAS PubMed Google Scholar
87. Frasca, D., Nguyen, D., Riley, R.L. & Blomberg, B.B. Decreased E12 and/or E47 transcription factor activity in the bone marrow as well as in the spleen of aged mice. J. Immunol. 170, 719–726 (2003).
    CAS PubMed Google Scholar
88. Van der Put, E., Frasca, D., King, A.M., Blomberg, B.B. & Riley, R.L. Decreased E47 in senescent B cell precursors is stage-specific and regulated posttranslationally by protein turn-over. J. Immunol. 173, 818–827 (2004).
    CAS PubMed Google Scholar
89. Li, H., Dai, M. & Zhuang, Y.A. T cell intrinsic role in a mouse model for primary Sjogren's syndrome. Immunity 21, 551–560 (2004).
    CAS PubMed Google Scholar
90. Taghon, T.N., David, E., Zuniga-Pflucker, J.C. & Rothenberg, E.V. Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 19, 965–978 (2005).
    CAS PubMed PubMed Central Google Scholar
91. Bailey, A.M. & Posakony, J.W. Suppressor hairless directly activates transcription of Enhancer of split complex genes in response to Notch receptor activity. Genes Dev. 9, 2609–2622 (1995).
    CAS PubMed Google Scholar
92. Murre, C. et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58, 537–544 (1989).
    CAS PubMed Google Scholar
93. Ordentlich, P. et al. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol. Cell. Biol. 18, 2230–2239 (1998).
    CAS PubMed PubMed Central Google Scholar
94. Nie, L., Xu, M., Vladimirova, A. & Sun, X.H. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J. 22, 5780–5792 (2003).
    CAS PubMed PubMed Central Google Scholar
95. Huang, Z., Nie, L., Xu, M. & Sun, X.H. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination. Mol. Cell. Biol. 24, 8951–8962 (2004).
    CAS PubMed PubMed Central Google Scholar
96. Engel, I. & Murre, C. Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc. Natl. Acad. Sci. USA 96, 996–1001 (1999).
    CAS PubMed PubMed Central Google Scholar
97. Kee, B.L., Bain, G. & Murre, C. Il-7Rα and E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO J. 21, 103–113 (2002).
    CAS PubMed PubMed Central Google Scholar
98. Kim, D., Peng, X.C. & Sun, X.H. Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice. Mol. Cell. Biol. 19, 8240–8253 (1999).
    CAS PubMed PubMed Central Google Scholar
99. Zhao, F., Vilardi, A., Neely, R.J. & Choi, J.K. Promotion of cell cycle progression by basic helix–loop–helix E2A. Mol. Cell. Biol. 21, 6346–6357 (2001).
    CAS PubMed PubMed Central Google Scholar
100. Peverali, F. et al. Regulation of G1 progression by E2A and Id helix–loop–helix proteins. EMBO J. 13, 4291–4301 (1994).
     CAS PubMed PubMed Central Google Scholar
101. Sicinska, E. et al. Requirements for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4, 451–456 (2003).
     CAS PubMed Google Scholar
102. Morrow, M.A., Mayer, E.W., Perez, C.A., Adlam, M. & Siu, G. Overexpression of the helix-loop-helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36, 491–503 (1999).
     CAS PubMed Google Scholar
103. Park, S.T., Nolan, G.P. & Sun, X.H. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells. J. Exp. Med. 189, 501–508 (1999).
     CAS PubMed PubMed Central Google Scholar
104. Engel, I. & Murre, C. 1999. Transcription factors in hematopoiesis. Curr. Opin. Genet. Dev. 9, 575–579 (1999).
     CAS PubMed Google Scholar
105. O'Neil, J., Shank, J., Cusson, N., Murre, C. & Kelliher, M. 2004. TAL1/SCL induces leukemia by inhibiting transcriptional activity of E47/HEB. Cancer Cell 5, 587–597 (2004).
     CAS PubMed Google Scholar
106. Aspland, S.E., Bendall, H.H. & Murre, C. The role of E2A/Pbx-1 in leukemogenesis. Oncogene 20, 5708–5717 (2001).
     CAS PubMed Google Scholar
107. Look, A.T. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastoid leukemia. Curr. Top. Microbiol. Immunol. 220, 45–53 (1997).
     CAS PubMed Google Scholar
108. Asp, J., Thornemo, M., Inerot, S. & Lindahl, A. The helix-loop-helix transcription factors Id1 and Id3 have a functional role in control of cell division in human normal and neoplastic chondrocytes. FEBS Lett. 438, 85–90 (1998).
     CAS PubMed Google Scholar
109. Nishimori, H. et al. The Id2 gene is a novel target of transcriptional activation by ES-ETS fusion proteins in Ewing family tumors. Oncogene 21, 8302–8309 (2002).
     CAS PubMed Google Scholar
110. Rockman, S.P. et al. Id2 is a target of the β-catenin/T cell factor pathway in colon carcinoma. J. Biol. Chem. 276, 45113–45119 (2001).
     CAS PubMed Google Scholar
111. Perk, J., Iavarone, A. & Benezra, R. Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5, 603–614 (2005).
     CAS PubMed Google Scholar

Download references